stars 1 stars 2 stars 3

Biogelx is helping people work in translational science, drug discovery and tissue engineering by 'making in vitro cell cultures more in vivo'. We do this through manufacturing and supplying 3D cell cultures that can be tuned to specific tissues and synthetic bio-inks that are reproducible, scalable, easy to handle and suitable for clinical decision making. Our portfolio of biomaterials is comprised of synthetic peptide hydrogels that act as extracellular-matrix environments to support cell growth. In addition, the chemical and physical properties of our biomaterials can be precisely tuned to replicate the characteristics of specific tissues so that the cells experience and engage with a realistic 3D environment. If you have interests in Biogelx 3D cell culture systems we would be delighted to talk to you, there is no cost to exploring potential opportunities. Tel: +44 (0) 1698 534655 Email: info@biogelx.com www.biogelx.com

Biogelx Questions

The Biogelx annual revenue was $1 million in 2026.

2 people are employed at Biogelx.

The NAICS codes for Biogelx are [541713, 54171, 541, 54, 5417].

The SIC codes for Biogelx are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users